• 1
    BondyPK, RosenbergLE, eds. Metabolic Control and Disease. 8th ed. Philadelphia, PA: W.B. Saunders; 1980: 15351578.
  • 2
    Carruthers M, Trinick TR, Wheeler MJ. The validity of androgen assays. Aging Male 2007; 10: 165172.
  • 3
    Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003; 58: 710717.
  • 4
    Golomb MR, Dick PT, MacGregor DL, et al. Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. J Child Neurol 2004; 19: 493497.
  • 5
    Salih MA, Abdel-Gader AG, Al-Jarallah AA, et al. Perinatal stroke in Saudi children. Clinical features and risk factors. Saudi Med J 2006; 27(suppl 1): S35S40.
  • 6
    Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119: 495501.
  • 7
    Golomb MR, Fullerton HJ, Nowak-Göttl U, deVeber G. Male predominance in childhood ischaemic stroke and cerebral sinovenous thrombosis: findings from the International Pediatric Stroke Study. Stroke 2009; 40: 5257.
  • 8
    Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood—a 5-year follow-up study. Lancet 2002; 360: 15401545.
  • 9
    Bernard TJ, Goldenberg NA, Tripputi M, Manco-Johnson MJ, Niederstadt T, Nowak-Göttl U. Anticoagulation in childhood-onset arterial ischemic stroke with Nonmoyamoya arteriopathy: findings from the colorado and German (COAG) collaboration. Stroke 2009; 40: 28692871.
  • 10
    Kenet G, Kirkham F, Niederstadt T, et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurology 2007; 6: 595603.
  • 11
    Tanner JM. Growth at Adolescence. 2nd ed. Oxford, UK: Blackwell Scientific Publications; 1962.
  • 12
    Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163F167.
  • 13
    McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62: 164.
  • 14
    Frankle MA, Eichberg R, Zachariah S. Anabolic-androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehabil 1988; 69: 632633.
  • 15
    Lowe GD, Thompson JE, Reavey MM, et al. Mesterolone: thrombosis during treatment and a study of its prothrombotic effects. Br J Clin Pharmacol 1979; 7: 107109.
  • 16
    Shiozawa Z, Yamada H, Mabuchi C, et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol 1982; 12: 578580.
  • 17
    Nagleberg SB, Lave L, Loriaux DL, et al. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986; 314: 645650.
  • 18
    Pilo R, Aharony D, Raz A. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid and metabolism. Thromb Haemost 1981; 46: 538542.
  • 19
    Winkler UH. Effects of androgens on haemostasis. Maturitas 1996; 24: 147155.
  • 20
    Nakao J, Chang WC, Murotas I, Orimo H. Testosterone inhibits prostacyclin production by rat aortic smooth muscle cells in culture. Atherosclerosis 1981; 39: 203209.
  • 21
    Pawlowitzki ICH, Diekstall P, Ming P, Balleisen L. Abnormal platelet function in Kallman syndrome. Lancet 1986; 8499: 166.
  • 22
    Anderson RA, Ludlam CA, Wu FCW. Haemostatic effects of supraphysiological levels of testosterone in normal men. Thromb Haemost 1995; 74: 693697.
  • 23
    Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clin Chem 2003; 49: 13811395.